Platyspondylic lethal chondrodysplasia

Platyspondylic Lethal Chondrodysplasia (PLCD) is a rare genetic disorder that affects the development of bone and cartilage, particularly in the spine and long bones. This condition is part of a group of disorders known as skeletal dysplasias, which are characterized by abnormalities in the size and shape of the limbs, trunk, and skull. PLCD is classified under the broader category of chondrodysplasias, disorders affecting the cartilage and resulting in skeletal deformities. The term "platyspondylic" refers to the flattening of the vertebral bodies seen in this condition, while "lethal" indicates the severity of the disorder, often leading to death in infancy or early childhood.

Causes

PLCD is caused by mutations in specific genes involved in the growth and development of bone and cartilage. The most commonly implicated gene is FGFR3 (Fibroblast Growth Factor Receptor 3), which plays a crucial role in skeletal development. Mutations in this gene disrupt the normal signaling pathways necessary for bone growth and maintenance, leading to the characteristic features of PLCD.

Symptoms

The symptoms of PLCD are present at birth and may include severe short stature, underdeveloped lungs, and distinctive facial features such as a prominent forehead, flat nose, and cleft palate. The spine shows significant abnormalities, with flattened vertebral bodies (platyspondyly) and irregular endplates. The long bones in the arms and legs are also shortened and bowed, contributing to the overall short stature.

Diagnosis

Diagnosis of PLCD is primarily based on physical examination and imaging studies, such as X-rays, which reveal the characteristic skeletal abnormalities. Genetic testing can confirm the diagnosis by identifying mutations in the FGFR3 gene or other genes associated with the condition.

Treatment

There is no cure for PLCD, and treatment focuses on managing symptoms and improving quality of life. This may include surgical interventions to correct skeletal deformities, respiratory support for underdeveloped lungs, and physical therapy to enhance mobility. Genetic counseling is recommended for families affected by PLCD to discuss the risk of recurrence in future pregnancies.

Prognosis

The prognosis for individuals with PLCD is generally poor, with most affected infants experiencing respiratory failure due to underdeveloped lungs and chest cavity. However, the severity of the condition can vary, and some individuals with milder forms of the disorder may survive into childhood or adolescence with appropriate medical and surgical management.

Platyspondylic lethal chondrodysplasia Resources
Latest articles Most recent articles Ongoing trials	Wikipedia